165 related articles for article (PubMed ID: 25928096)
1. Characterization of 46 patient-specific BCR-ABL1 fusions and detection of SNPs upstream and downstream the breakpoints in chronic myeloid leukemia using next generation sequencing.
Linhartova J; Hovorkova L; Soverini S; Benesova A; Jaruskova M; Klamova H; Zuna J; Machova Polakova K
Mol Cancer; 2015 Apr; 14():89. PubMed ID: 25928096
[TBL] [Abstract][Full Text] [Related]
2. Novel BCR-ABL1 fusion identified by targeted next-generation sequencing in a patient with an atypical myeloproliferative neoplasm.
Frederick L; Beardell F; Viswanatha DS
Hum Pathol; 2014 Aug; 45(8):1784-9. PubMed ID: 24927924
[TBL] [Abstract][Full Text] [Related]
3. Novel Illumina-based next generation sequencing approach with one-round amplification provides early and reliable detection of BCR-ABL1 kinase domain mutations in chronic myeloid leukemia.
Romzova M; Smitalova D; Tom N; Jurcek T; Culen M; Zackova D; Mayer J; Racil Z
Br J Haematol; 2020 May; 189(3):469-474. PubMed ID: 32037516
[TBL] [Abstract][Full Text] [Related]
4. Next-Generation Sequencing-Assisted DNA-Based Digital PCR for a Personalized Approach to the Detection and Quantification of Residual Disease in Chronic Myeloid Leukemia Patients.
Alikian M; Ellery P; Forbes M; Gerrard G; Kasperaviciute D; Sosinsky A; Mueller M; Whale AS; Milojkovic D; Apperley J; Huggett JF; Foroni L; Reid AG
J Mol Diagn; 2016 Mar; 18(2):176-89. PubMed ID: 26857065
[TBL] [Abstract][Full Text] [Related]
5. Rapid identification of compound mutations in patients with Philadelphia-positive leukaemias by long-range next generation sequencing.
Kastner R; Zopf A; Preuner S; Pröll J; Niklas N; Foskett P; Valent P; Lion T; Gabriel C
Eur J Cancer; 2014 Mar; 50(4):793-800. PubMed ID: 24365090
[TBL] [Abstract][Full Text] [Related]
6. Differential Regulation of Telomeric Complex by
Deregowska A; Pepek M; Pruszczyk K; Machnicki MM; Wnuk M; Stoklosa T
Genes (Basel); 2020 Sep; 11(10):. PubMed ID: 33003326
[TBL] [Abstract][Full Text] [Related]
7. Detection of BCR-ABL1 kinase domain mutations causing imatinib resistance in chronic myelogenous leukemia.
Moore FR; Yang F; Press RD
Methods Mol Biol; 2013; 999():25-39. PubMed ID: 23666688
[TBL] [Abstract][Full Text] [Related]
8. Quantitative Analysis of Mutant Subclones in Chronic Myeloid Leukemia: Comparison of Different Methodological Approaches.
Preuner S; Barna A; Frommlet F; Czurda S; Konstantin B; Alikian M; Machova Polakova K; Sacha T; Richter J; Lion T; Gabriel C
Int J Mol Sci; 2016 Apr; 17(5):. PubMed ID: 27136541
[TBL] [Abstract][Full Text] [Related]
9. Mutational analysis in BCR-ABL1 positive leukemia by deep sequencing based on nanopore MinION technology.
Minervini CF; Cumbo C; Orsini P; Anelli L; Zagaria A; Impera L; Coccaro N; Brunetti C; Minervini A; Casieri P; Tota G; Russo Rossi A; Specchia G; Albano F
Exp Mol Pathol; 2017 Aug; 103(1):33-37. PubMed ID: 28663031
[TBL] [Abstract][Full Text] [Related]
10. Use of mate-pair sequencing to characterize a complex cryptic BCR/ABL1 rearrangement observed in a newly diagnosed case of chronic myeloid leukemia.
Peterson JF; Pitel BA; Smoley SA; Smadbeck JB; Johnson SH; Vasmatzis G; Kearney HM; Greipp PT; Hoppman NL; Baughn LB; Ketterling RP
Hum Pathol; 2019 Jul; 89():109-114. PubMed ID: 30267776
[TBL] [Abstract][Full Text] [Related]
11. Characterization of a novel variant BCR-ABL1 fusion transcript in a patient with chronic myeloid leukemia: Implications for molecular monitoring.
Crampe M; Haslam K; Kelly J; Conneally E; Langabeer SE
Hematol Oncol Stem Cell Ther; 2017 Jun; 10(2):85-88. PubMed ID: 27013275
[TBL] [Abstract][Full Text] [Related]
12. Next-generation sequencing for BCR-ABL1 kinase domain mutation testing in patients with chronic myeloid leukemia: a position paper.
Soverini S; Abruzzese E; Bocchia M; Bonifacio M; Galimberti S; Gozzini A; Iurlo A; Luciano L; Pregno P; Rosti G; Saglio G; Stagno F; Tiribelli M; Vigneri P; Barosi G; Breccia M
J Hematol Oncol; 2019 Dec; 12(1):131. PubMed ID: 31801582
[TBL] [Abstract][Full Text] [Related]
13. Cytogenetic, fluorescence in situ hybridization, and genomic array characterization of chronic myeloid leukemia with cryptic BCR-ABL1 fusions.
Shao L; Miller S; Keller-Ramey J; Zhang Y; Roulston D
Cancer Genet; 2015; 208(7-8):396-403. PubMed ID: 26186983
[TBL] [Abstract][Full Text] [Related]
14. Differences in Variants in the Structural Domain of BCR-ABL1 Kinase between Chinese Han and Minority Patients with Chronic Myeloid Leukemia by Sanger Sequencing and Next-Generation Sequencing.
Abulaiti D; Tuerxun N; Wang H; Abulizi P; Zhao F; Liu Y; Hao J
Cytogenet Genome Res; 2022; 162(4):201-206. PubMed ID: 36167055
[TBL] [Abstract][Full Text] [Related]
15. Technical aspects and clinical applications of measuring BCR-ABL1 transcripts number in chronic myeloid leukemia.
Foroni L; Gerrard G; Nna E; Khorashad JS; Stevens D; Swale B; Milojkovic D; Reid A; Goldman J; Marin D
Am J Hematol; 2009 Aug; 84(8):517-22. PubMed ID: 19544476
[TBL] [Abstract][Full Text] [Related]
16. Fine structure of translocation breakpoints within the major breakpoint region in BCR-ABL1-positive leukemias.
Burmeister T; Gröger D; Kühn A; Hoelzer D; Thiel E; Reinhardt R
DNA Repair (Amst); 2011 Nov; 10(11):1131-7. PubMed ID: 21944569
[TBL] [Abstract][Full Text] [Related]
17. Genomic BCR-ABL1 breakpoints in pediatric chronic myeloid leukemia.
Krumbholz M; Karl M; Tauer JT; Thiede C; Rascher W; Suttorp M; Metzler M
Genes Chromosomes Cancer; 2012 Nov; 51(11):1045-53. PubMed ID: 22887688
[TBL] [Abstract][Full Text] [Related]
18. Clonal distribution of BCR-ABL1 mutations and splice isoforms by single-molecule long-read RNA sequencing.
Cavelier L; Ameur A; Häggqvist S; Höijer I; Cahill N; Olsson-Strömberg U; Hermanson M
BMC Cancer; 2015 Feb; 15():45. PubMed ID: 25880391
[TBL] [Abstract][Full Text] [Related]
19. BCR-ABL1 lymphoblastic leukaemia is characterized by the deletion of Ikaros.
Mullighan CG; Miller CB; Radtke I; Phillips LA; Dalton J; Ma J; White D; Hughes TP; Le Beau MM; Pui CH; Relling MV; Shurtleff SA; Downing JR
Nature; 2008 May; 453(7191):110-4. PubMed ID: 18408710
[TBL] [Abstract][Full Text] [Related]
20. High frequency of BTG1 deletions in patients with BCR-ABL1-positive acute leukemia.
Xie J; Wang Q; Wang Q; Yao H; Wen L; Ma L; Wu D; Chen S
Cancer Genet; 2014 May; 207(5):226-30. PubMed ID: 24998463
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]